In vitro catheter and sorbent-based method for clearance of radiocontrast material during cerebral interventions

Cardiovascular Revascularization Medicine

Volumn 14, Issue 4, 2013, Pages 207-212

  Angheloiu, George O ^a,b   Hänscheid, Heribert ^c   Reiners, Christoph ^c   Anderson, William D ^d   Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b DuBois Regional Medical Center   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Divisions of Cardiology   (United States)

Author keywords

Catheter; Contrast; MOCS; Nephropathy; Sorbent

Indexed keywords

CONTRAST MEDIUM; RESIN; SORBENT;

ARTICLE; BRAIN CIRCULATION; CARDIOVASCULAR SYSTEM; CATHETER; CATHETERIZATION; CEREBRAL REVASCULARIZATION; DRUG CLEARANCE; IN VITRO STUDY; PRIORITY JOURNAL; RELIABILITY; SUCTION;

CATHETER; CONTRAST; MOCS; NEPHROPATHY; SORBENT;

CATHETERIZATION; CATHETERS; CONTRAST MEDIA; HUMANS; MODELS, CARDIOVASCULAR; POLYMERS; REPRODUCIBILITY OF RESULTS; SUCTION;

EID: 84881373914     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2013.03.001     Document Type: Article

References (10)

1. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002, 105:2259-2264.
2. Michishita I., Fujii Z. A novel contrast removal system from the coronary sinus using an adsorbing column during coronary angiography in a porcine model. J Am Coll Cardiol 2006, 47:1866-1870.
3. Movahed M.R., Wong J., Molloi S. Removal of iodine contrast from coronary sinus in swine during coronary angiography. J Am Coll Cardiol 2006, 47:465-467.
4. Tsuchida K., Yoshimura R., Nakatani T., Takemoto Y. Blood purification for critical illness: cytokines adsorption therapy. Ther Apher Dial 2006, 10:25-31.
5. Reiners C., Hänscheid H., Lassmann M., Tiemann M., Kreissl M., Rendl J., et al. X-ray fluorescence analysis (XFA) of thyroidal iodine content (TIC) with an improved measuring system. Exp Clin Endocrinol Diabetes 1998, 106(Suppl 3):S31-S33.
6. Pannu N., Wiebe N., Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006, 295:2765-2779.
7. Marenzi G., Marana I., Lauri G., Assanelli E., Grazi M., Campodonico J., et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003, 349:1333-1340.
8. Angheloiu G.O., Hänscheid H., Wen X., Anderson W.D., Kellum J.A. Experimental first-pass method for testing and comparing sorbent polymers used in the clearance of iodine contrast materials. Blood Purif 2012, 34:34-39.
9. Svaland M.G., Haider T., Langseth-Manrique K., Andrew E., Hals P.A. Human pharmacokinetics of iodixanol. Invest Radiol 1992, 27:130-133.
10. DiLeo M.V., Kellum J.A., Federspiel W.J. A simple mathematical model of cytokine capture using a hemoadsorption device. Ann Biomed Eng 2009, 37:222-229.